The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers

Authors

  • Bengt Johansson Department of General Oncology, Örebro University Hospital, Örebro, Sweden
  • Mona Ridderheim Department of Oncology, University Hospital, Lund, Sweden
  • Bengt Glimelius Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

DOI:

https://doi.org/10.1080/02841860500355942

Abstract

A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. In prostate cancer it is estimated that annually about 300 patients and in gynaecological cancer about 50 patients, are candidates for proton beam therapy. Owing to major uncertainties, it has not been possible to give an estimate of the number of potential patients with urinary bladder cancer.

Downloads

Download data is not yet available.

Downloads

Published

2005-01-01

How to Cite

Johansson, B. ., Ridderheim, M. ., & Glimelius, B. . (2005). The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers. Acta Oncologica, 44(8), 890–895. https://doi.org/10.1080/02841860500355942